Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 94,876 | 95,442 | 68,164 | 72,031 | 80,630 |
| Cost of Goods | 14,403 | 14,035 | 13,769 | 13,410 | 13,084 |
| Gross Profit | 80,473 | 81,407 | 54,395 | 58,621 | 67,546 |
| Operating Expenses | 59,605 | 67,013 | 78,794 | 60,664 | 57,548 |
| Operating Income | 21,271 | 14,429 | -23,630 | -1,633 | 10,082 |
| Interest Expense | 1,643 | 1,641 | 1,692 | 1,702 | 1,699 |
| Other Income | 8,791 | 8,428 | -72,553 | 10,963 | 11,435 |
| Pre-tax Income | 28,419 | 21,216 | -97,875 | 7,628 | 19,818 |
| Income Tax | 1,492 | 2,495 | -1,776 | 578 | 2,224 |
| Net Income Continuous | 26,927 | 18,721 | -96,099 | 7,050 | 17,594 |
| Net Income | $26,927 | $18,721 | $-96,099 | $7,050 | $17,594 |
| EPS Basic Total Ops | 0.23 | 0.16 | -0.77 | 0.06 | 0.13 |
| EPS Basic Continuous Ops | 0.23 | 0.16 | -0.77 | 0.06 | 0.13 |
| EPS Diluted Total Ops | 0.21 | 0.14 | -0.77 | 0.07 | 0.12 |
| EPS Diluted Continuous Ops | 0.20 | 0.14 | -0.77 | 0.08 | 0.11 |
| EPS Diluted Before Non-Recurring Items | 0.21 | 0.14 | -0.11 | 0.05 | 0.12 |
| EBITDA(a) | $22,166 | $14,770 | $-23,731 | $-2,215 | $8,709 |